Form 8-K · Current report
Jacobs Solutions 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0000052988
- Accession no.
- 0001628280-26-052563
Summary
Jacobs Solutions reported fiscal third-quarter 2026 gross revenue of $4.1 billion, up 34.5% year over year, adjusted net revenue of $2.4 billion, up 8.3%, and record backlog of $28.9 billion, and raised its fiscal 2026 guidance for adjusted net revenue growth and adjusted EPS for the third consecutive quarter. GAAP net earnings fell to $137.4 million and GAAP EPS to $1.16, which Chair and CEO Bob Pragada and CFO Venk Nathamuni attributed to a temporarily higher tax rate tied to the PA Consulting acquisition transaction, while adjusted EPS rose 13.6% to $1.84.
Key points
- Gross revenue rose 34.5% y/y to $4.1 billion; adjusted net revenue rose 8.3% y/y to $2.4 billion.
- Adjusted EBITDA increased 16.7% y/y to $366.8 million; GAAP EPS was $1.16 versus $1.56 a year earlier and adjusted EPS was $1.84 versus $1.62.
- Backlog reached $28.9 billion, up 27.3% y/y, with Q3 book-to-bill of 1.5x and a trailing-twelve-month ratio of 1.4x.
- Fiscal 2026 outlook: adjusted net revenue growth of 9.5% to 10.0%, adjusted EBITDA margin of 14.7% to 14.8%, and adjusted EPS of $7.20 to $7.30.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On August 4, 2026, Jacobs Solutions Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 26, 2026 and certain other financial information. A copy of the press release is attached to this Form 8-K as Exhibit 99.1. Item 9.01 Financial Statements and Exhibits (d)Exhibits: The following exhibits are furnished as part of this Report pursuant to Item 2.02. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.